The H2 Blockers' Rx-to OTC Switch: For Whom Will It Spell Relief?

DSpace/Manakin Repository

The H2 Blockers' Rx-to OTC Switch: For Whom Will It Spell Relief?

Citable link to this page

. . . . . .

Title: The H2 Blockers' Rx-to OTC Switch: For Whom Will It Spell Relief?
Author: Kisloff, Michelle A.
Citation: The H2 Blockers' Rx-to OTC Switch: For Whom Will It Spell Relief? (1995 Third Year Paper)
Full Text & Related Files:
Abstract: Tylenol. Advil. Monistat 7. Imodium AD. These are some of the most commonly used, widely available, and successful drugs in the United States. All of them began as drugs only available by a prescription. All of them made a successful prescription-only to over-the-counter (Rx-to-OTC) switch through the switch" mechanisms of the Food and Drug Administration (FDA). Due to the amount of money that pharmaceutical companies can make with an Rx-to-OTC switch, the FDA has received dozens of switch requests in the last few years, and it expects to receive many more in the near future.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846781

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters